Effectdossier · gearchiveerd kwartaal
OCUL
Ocular Therapeutix, Inc. · Healthcare · Biotechnology
15Gevolgde houders
+1Δ houders
57.50MGehouden aandelen
$533.65MGerapporteerde waarde
+1Nieuwe posities
−0Uitstappen
Momentum-inputs (vergelijkbare managers):
breedte van houders +7.1% ·
aandelenstroom -2.3% ·
netto nieuwe posities +6.7%
— formule
Versnippering van eigendom — meer houders, kleinere totale positie
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 90 | -8 | 115.87M | $1.14B | +4 | −12 |
| Q1 2026 | 101 | +4 | 114.41M | $983.07M | +11 | −8 |
| Q4 2025 | 96 | +1 | 115.21M | $1.40B | +2 | — |
| Q3 2025 | 18 | 0 | 82.57M | $965.26M | +1 | −1 |
| Q2 2025 | 15 | +1 | 57.50M | $533.65M | +1 | — |
| Q1 2025 | 11 | 0 | 20.34M | $149.08M | +1 | −1 |
| Q4 2024 | 11 | +1 | 19.58M | $167.25M | +2 | −1 |
| Q3 2024 | 9 | +1 | 15.07M | $131.15M | +1 | — |
| Q2 2024 | 8 | — | 16.30M | $111.49M | — | — |
Wie het bezit · Q2 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 19.61M | — | $181.96M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 19.61M | — | $181.96M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 19.61M | — | $181.96M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 19.61M | — | $181.96M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Fidelity (FMR) ✦ | 19.61M | — | $181.96M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 10.55M | — | $97.87M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 10.55M | — | $97.87M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 10.55M | — | $97.87M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 10.55M | — | $97.87M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 10.55M | — | $97.87M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 10.55M | — | $97.87M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 10.55M | — | $97.87M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 10.55M | — | $97.87M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 10.55M | — | $97.87M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 10.55M | — | $97.87M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 10.55M | — | $97.87M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 10.55M | — | $97.87M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (passief) | 10.55M | — | $97.87M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (passief) | 8.39M | — | $77.88M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | The Vanguard Group ✦ (passief) | 8.39M | — | $77.88M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | The Vanguard Group ✦ (passief) | 8.39M | — | $77.88M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | The Vanguard Group ✦ (passief) | 8.39M | — | $77.88M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | The Vanguard Group ✦ (passief) | 8.39M | — | $77.88M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Citadel Advisors ✦ | 4.89M | +1.6% | $45.34M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Citadel Advisors ✦ | 4.89M | +1.6% | $45.34M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | Adage Capital Partners ✦ | 3.89M | -25.2% | $36.10M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 27 | State Street Global Advisors ✦ (passief) | 3.51M | +3.5% | $32.56M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 28 | Geode Capital Management ✦ (passief) | 3.28M | -4.0% | $30.48M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 29 | Geode Capital Management ✦ (passief) | 3.28M | -4.0% | $30.48M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 30 | Point72 Asset Management ✦ | 1.90M | -2.0% | $17.67M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 31 | Wellington Management ✦ | 503.99K | +11.3% | $4.68M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | Wellington Management ✦ | 503.99K | +11.3% | $4.68M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | Wellington Management ✦ | 503.99K | +11.3% | $4.68M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | Wellington Management ✦ | 503.99K | +11.3% | $4.68M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 35 | Wellington Management ✦ | 503.99K | +11.3% | $4.68M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 36 | Renaissance Technologies ✦ | 410.05K | -9.7% | $3.81M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 37 | T. Rowe Price ✦ | 126.37K | +0.5% | $1.17M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 38 | Millennium Management ✦ | 119.15K | Nieuw | $1.11M | 0.0% | New | 1 | SEC ↗ |
| 39 | AQR Capital Management ✦ | 111.02K | +609.4% | $1.03M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 40 | AQR Capital Management ✦ | 111.02K | +609.4% | $1.03M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 41 | AQR Capital Management ✦ | 111.02K | +609.4% | $1.03M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 42 | AQR Capital Management ✦ | 111.02K | +609.4% | $1.03M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 43 | Two Sigma Investments ✦ | 110.83K | -76.0% | $1.03M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 44 | D. E. Shaw & Co. ✦ | 102.83K | +71.0% | $954,290 | 0.0% | ▲ Add | 3 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Millennium Management | $1.11M | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 266 houders, 206.22M aandelen, $1.70B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q2 2025 ·
Methodologie ·
Verkrijg dit via de API